Stem Cell Law, Hope, and Barriers

Sugar Crush: And Now, The Rest of the Story... · Mar 17, 2026 · 19:07

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

This episode explores the complicated landscape of stem cell therapy regulation in the United States, focusing on the FDA's restrictive definitions and their impact on doctors and patients. Dr. Rick Jacoby and his guest discuss the legal hurdles that drive Americans to seek treatment abroad, the role of big pharma, and the challenges of pursuing innovation. The conversation highlights the tension between scientific potential and regulatory roadblocks, leaving many to question the future of regenerative medicine in America.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.